D'ABUNDO, Lucilla
 Distribuzione geografica
Continente #
NA - Nord America 3.021
EU - Europa 1.654
AS - Asia 1.379
SA - Sud America 186
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 34
OC - Oceania 3
Totale 6.373
Nazione #
US - Stati Uniti d'America 2.920
SG - Singapore 494
DE - Germania 475
CN - Cina 325
PL - Polonia 300
IT - Italia 290
FI - Finlandia 265
VN - Vietnam 169
BR - Brasile 133
HK - Hong Kong 96
BD - Bangladesh 88
GB - Regno Unito 82
UA - Ucraina 63
CA - Canada 58
TR - Turchia 44
ID - Indonesia 39
SE - Svezia 39
FR - Francia 38
JP - Giappone 32
IN - India 27
MX - Messico 27
AR - Argentina 25
RU - Federazione Russa 23
ES - Italia 16
NL - Olanda 14
CZ - Repubblica Ceca 11
IQ - Iraq 11
ZA - Sudafrica 11
LT - Lituania 9
AT - Austria 7
CO - Colombia 7
UZ - Uzbekistan 6
EG - Egitto 5
MY - Malesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
VE - Venezuela 5
BO - Bolivia 4
CL - Cile 4
KR - Corea 4
MA - Marocco 4
AU - Australia 3
EC - Ecuador 3
HR - Croazia 3
JM - Giamaica 3
OM - Oman 3
PH - Filippine 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AZ - Azerbaigian 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CY - Cipro 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TH - Thailandia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.278
Città #
Ashburn 411
Munich 409
Singapore 303
Warsaw 297
San Jose 259
Fairfield 247
Helsinki 197
Woodbridge 174
Houston 135
Beijing 127
Seattle 119
Chandler 110
Santa Clara 103
Wilmington 99
Cambridge 95
Hong Kong 91
Ann Arbor 77
Ferrara 75
Jacksonville 71
New York 71
Council Bluffs 68
Los Angeles 65
Ho Chi Minh City 51
Dallas 50
Jakarta 34
Milan 34
Tokyo 32
Hanoi 31
Nanjing 26
Shanghai 26
London 25
Turku 24
Montreal 23
Phoenix 23
Orem 22
Atlanta 21
Lauterbourg 21
Izmir 20
Jyväskylä 20
Chicago 19
Princeton 19
São Paulo 19
Rome 17
Bologna 16
Boardman 15
San Diego 15
Toronto 15
Turin 15
Mexico City 14
Denver 13
Nanchang 11
Dong Ket 10
Nuremberg 10
Buffalo 9
Manchester 9
Mountain View 9
San Francisco 9
Stockholm 9
Chennai 8
Johannesburg 8
Shenyang 8
Boston 7
Da Nang 7
Falls Church 7
Redwood City 7
Addison 6
Bremen 6
Brno 6
Haiphong 6
Hefei 6
Poplar 6
Tashkent 6
Baghdad 5
Dearborn 5
Guangzhou 5
Hebei 5
Naples 5
Pavia 5
Salt Lake City 5
Somerville 5
Tianjin 5
Vancouver 5
Vienna 5
Washington 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Brooklyn 4
Cagliari 4
Changsha 4
Guarulhos 4
Honolulu 4
Kunming 4
Lancaster 4
Moscow 4
New Delhi 4
Ningbo 4
Ninh Bình 4
Quảng Ngãi 4
Riyadh 4
Totale 4.558
Nome #
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 409
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 375
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 319
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 306
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 304
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 302
Studi pre-clinici per lo sviluppo di approcci terapeutici basati sui microRNA in un modello di Leucemia Linfatica Cronica 289
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 275
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 269
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 262
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 248
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 247
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 242
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 240
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 237
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 208
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy 196
Mutated beta-catenin evades a microRNA-dependent regulatory loop 192
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 188
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 176
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 174
FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells 167
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 142
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 133
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells 106
P3.12.20 VAF of EGFR Mutations in Relation to Early Tumor Shrinkage or Deepness of Response During Osimertinib in NSCLC Patients 106
null 89
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer 69
null 63
The Effects of Variant Allele Frequency for EGFR Mutation on Early Tumor Shrinkage and Deepness of Response to Osimertinib in Patients with Metastatic Non-Small Cell Lung Cancer: An Exploratory Analysis 40
Totale 6.373
Categoria #
all - tutte 24.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.145


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022211 0 20 23 3 10 13 10 15 6 18 25 68
2022/2023246 19 19 12 29 44 33 17 17 30 3 13 10
2023/2024238 13 21 9 5 17 48 12 48 1 9 4 51
2024/20251.393 20 17 59 37 90 186 217 144 279 91 111 142
2025/20262.351 235 52 136 276 341 159 347 124 217 230 156 78
2026/2027179 55 124 0 0 0 0 0 0 0 0 0 0
Totale 6.373